Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 681

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 681
---
ominator:                                                                         |     |                       |             |   |
| Weighted average shares outstanding - basic and diluted(2)                           |     |                       |  52,798,639 |   |
| Net loss per share:                                                                  |     |                       |             |   |
| Pro forma net loss attributable to common stockholders per share - basic and diluted |     | $                     |       (1.11 | ) |
| Excluded securities:                                                                 |     |                       |             |   |
| TuHURA Options(2)                                                                    |     |                       |   6,587,057 |   |
| CVR Shares(2)                                                                        |     |                       |   1,539,938 |   |
| TuHURA Warrants(2)                                                                   |     |                       |   9,213,983 |   |

| (1) | Pro forma net loss attributable to common stockholders includes the related pro forma adjustments as 
 referred to within the section “Unaudited Pro Forma Condensed Combined Financial Information.”       |

| (2) | The potentially dilutive outstanding securities were excluded from the computation of pro forma net loss                                                                                                                                                 
 attributable to common stockholders per share, basic and diluted, because their effect would have been anti-dilutive and/or issuance or vesting of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the 
 end of the periods presented.                                                                                                                                                                                                                            |

455

DESCRIPTION OF KINETA’S SECURITIES

The following description sets forth certain material terms and provisions of the securities of Kineta that are registered under
Section 12 of the Securities Exchange Act of 1934, as amended. This description also summarizes relevant provisions of Delaware law. The following summary does not purport to be complete and is subject to, and is qualified in its entirety by
reference to, the applicable provisions of Delaware law and Kineta’s amended and restated certificate of incorporation, Kineta’s amended and restated bylaws and the Registration Rights Agreement, as amended, which are filed as exhibits to
Kineta’s most recent Annual Report on Form 10-K. Kineta encourages you to read Kineta’s amended and restated certificate of incorporation, Kineta’s amended and restated bylaws, the Registration
Rights Agreement, as amended, and the applicable provisions of the DGCL for additional information.

Authorized Capital Stock

Kineta is authorized to issue 125,000,000 shares of common stock, par value $0.001 per share